Author:
Cruz-Rangel Armando,Gómez-Romero Laura,Cisneros-Villanueva Mireya,de Anda Jáuregui G.,Luna-Pineda Victor,Cedro-Tanda Alberto,Campos-Romero Abraham,Mendoza-Vargas Alfredo,Reyes-Grajeda J. P.,Hidalgo-Miranda Alfredo,Herrera Luis A.,Hidalgo-Miranda Alfredo,Mendoza-Vargas Alfredo,Reyes-Grajeda Juan P.,Vadillo-Ortega Felipe,Cedro-Tanda Alberto,Peñaloza Fernando,Frías-Jimenez Emmanuel,Ruiz Rosaura,Angulo Ofelia,Cisneros-Villanueva Mireya,Hernandez-Morales Jose S.,Moreno Bernardo,Hernández-Cruz Irwin A.,Herrera César A.,García Francisco,González-Woge Miguel A.,Munguía-Garza Paulina,Luna-Maldonado Fernando,Sanchez-Vizcarra Antonia,Osnaya Vincent G.,Medina-Molotla Nelly,Alfaro-Mora Yair,Caceres-Gutiérrez Rodrigo E.,Tolentino-Garcia Laura,Moreno-Camacho José Luis,Rodriguez-Gallegos Jorge,Esparza Marco A. Luna-Ruiz,Rojas Miguel Ángel Fernández,Rosas-Escobar Patricia,Román-González Sergio A.,Escobar-Arrazola Marco A.,Canseco-Mendez Julio C.,Ortiz-Soriano Diana R.,Dominguez-Ortiz Julieta,Gonzalez-Barrera Ana D.,Aparicio-Bautista Diana I.,Rodriguez Martinez Griselda,Rangel Armando Cruz,Herrera Luis A.,Vadillo-Ortega Felipe,
Abstract
AbstractEnd-point RT-PCR is a suitable alternative diagnostic technique since it is cheaper than RT-qPCR tests and can be implemented on a massive scale in low- and middle-income countries. In this work, a bioinformatic approach to guide the design of PCR primers was developed, and an alternative diagnostic test based on end-point PCR was designed. End-point PCR primers were designed through conservation analysis based on kmer frequency in SARS-CoV-2 and human respiratory pathogen genomes. Highly conserved regions were identified for primer design, and the resulting PCR primers were used to amplify 871 nasopharyngeal human samples with a previous RT-qPCR based SARS-CoV-2 diagnosis. The diagnostic test showed high accuracy in identifying SARS-CoV-2-positive samples including B.1.1.7, P.1, B.1.427/B.1.429 and B.1.617.2/ AY samples with a detection limit of 7.2 viral copies/µL. In addition, this test could discern SARS-CoV-2 infection from other viral infections with COVID-19-like symptomatology. The designed end-point PCR diagnostic test to detect SARS-CoV-2 is a suitable alternative to RT-qPCR. Since the proposed bioinformatic approach can be easily applied in thousands of viral genomes and over highly divergent strains, it can be used as a PCR design tool as new SARS-CoV-2 variants emerge. Therefore, this end-point PCR test could be employed in epidemiological surveillance to detect new SARS-CoV-2 variants as they emerge and propagate.
Funder
Secretaría de Educación, Ciencia, Tecnología e Innovación de la Ciudad de México
Publisher
Springer Science and Business Media LLC